Conavi Medical (QB)【CNVIF】銘柄情報

Conavi Medical Corporation (QB) (CNVIF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.16166

( -1.14% )

買値

0.1394

売値

0.209

出来高

19,419

0.1546 日の範囲 0.1718

0.1457 52 週間の範囲 0.555

時価総額

16.73M

前日終値

0.16352

始値

0.1546

時刻

0.16225

最終取引時間

財務取引量

US$ 3,259

VWAP

0.167851

平均取引量 (3 か月)

US$ 54,023

発行済株式数

103,491,756

配当利回り

PER

-1.06

1 株当たり利益 (EPS)

-0.22

歳入

778k

純利益

-17.85M

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co... Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada. 詳細を表示

セクター

Healthcare

業界

Medical Equipment & Supplies

ウェブサイト

www.conavi.com

本社

Toronto, Canada

設立

Conavi Medical Corporation (QB) is listed in the Healthcare sector of the その他OTC with ticker CNVIF. The last closing price for Conavi Medical (QB) was US$0.16. Over the last year, Conavi Medical (QB) shares have traded in a share price range of US$ 0.1457 to US$ 0.555.

Conavi Medical (QB) currently has 103,491,756 shares in issue. The market capitalisation of Conavi Medical (QB) is US$16.73 million. Conavi Medical (QB) has a price to earnings ratio (PE ratio) of -1.06.

Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights

- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System- Wins Multiple Industry...

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

PRELIMINARY PROSPECTUS ACCESSIBLE ON SEDAR+ NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES OR FOR...

Conavi Medical Awarded 2026 TAG Innovation Award

TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI;...

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

- First co-registered and co-aligned IVUS-OCT Platform for Intravascular Imaging - Company Positioned for U.S...

Conavi Medical Announces Results from Its Annual General Meeting of Shareholders

TORONTO, April 02, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical”...

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

- Successfully Closes $12M Public Offering, Strengthens Balance Sheet and Supports Anticipated U.S. Launch...

Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

TORONTO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”), a leader in...

Conavi Medical Corp. Announces Closing of $12M Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 13...

Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES A&R FINAL...

Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights

Next-Generation Novasight Hybrid™ System Submitted to U.S. FDA for 510(k) Clearance U.S. and European Class 1A...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01784	-9.93871866295	0.1795	0.185	0.1457	11805	0.16719873	CS
4	-0.02154	-11.7576419214	0.1832	0.2204	0.1457	15598	0.17901204	CS
12	-0.11774	-42.1403006442	0.2794	0.4255	0.1457	44813	0.2964365	CS
26	-0.22334	-58.0103896104	0.385	0.43131	0.1457	38056	0.30329455	CS
52	-0.12334	-43.2771929825	0.285	0.555	0.1457	27298	0.32963066	CS
156	-0.66524	-80.4498730197	0.8269	0.87	0.0007	20325	0.33615645	CS
260	-0.66524	-80.4498730197	0.8269	0.87	0.0007	20325	0.33615645	CS

CNVIF - Frequently Asked Questions (FAQ)

What is the current Conavi Medical Corporation (QB) share price?

The current share price of Conavi Medical Corporation (QB) is US$ 0.16166

How many Conavi Medical Corporation (QB) shares are in issue?

Conavi Medical Corporation (QB) has 103,491,756 shares in issue

What is the market cap of Conavi Medical Corporation (QB)?

The market capitalisation of Conavi Medical Corporation (QB) is USD 16.73M

What is the 1 year trading range for Conavi Medical Corporation (QB) share price?

Conavi Medical Corporation (QB) has traded in the range of US$ 0.1457 to US$ 0.555 during the past year

What is the PE ratio of Conavi Medical Corporation (QB)?

The price to earnings ratio of Conavi Medical Corporation (QB) is -1.06

What is the cash to sales ratio of Conavi Medical Corporation (QB)?

The cash to sales ratio of Conavi Medical Corporation (QB) is 31.26

What is the registered address of Conavi Medical Corporation (QB)?

The registered address for Conavi Medical Corporation (QB) is 293 Lesmill Road, Toronto, Ontario, M3B 2V1

What is the Conavi Medical Corporation (QB) website address?

The website address for Conavi Medical Corporation (QB) is www.conavi.com/novasight/

Which industry sector does Conavi Medical Corporation (QB) operate in?

Conavi Medical Corporation (QB) operates in the Medical Equipment & Supplies sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Conavi Medical Corporation (QB) (CNVIF)

Conavi Medical Corporation (QB) (CNVIF) 銘柄情報

個人投資家向けのプロ仕様のツール。

主要統計と詳細

Conavi Medical Corporation (QB) について

CNVIF 最新ニュース

Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Conavi Medical Awarded 2026 TAG Innovation Award

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

Conavi Medical Announces Results from Its Annual General Meeting of Shareholders

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

Conavi Medical Corp. Announces Closing of $12M Public Offering

Conavi Medical Corp. Announces Filing of Amended & Restated Final Prospectus

Conavi Medical Reports Fiscal Year 2025 Results and Operational Highlights

Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights

Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants

Conavi Medical Awarded 2026 TAG Innovation Award

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging

Conavi Medical Announces Results from Its Annual General Meeting of Shareholders

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

Conavi Medical Highlights Peer-Reviewed Publication Demonstrating Advantages of Hybrid IVUS-OCT Imaging

Conavi Medical Corp. Announces Closing of $12M Public Offering

CNVIF - Frequently Asked Questions (FAQ)

CNVIF 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

ADVFNに参加する理由

プロトレーダー向けの高機能ツール

広告を削除する